Supernus Pharmaceuticals (NASDAQ:SUPN) is scheduled to announce Q4 earnings results on Tuesday, February 25th, after market close. The consensus EPS Estimate is $0.52 (+2500.0% Y/Y) and the consensus ...
S&P 500 E-Mini futures (ESH25) are down -0.21%, andMarch Nasdaq 100 E-Mini futures (NQH25) are down -0.39% this morning, ...